FDA Releases DTC Guidances; “Not The Last Word” On Ads, McClellan Says

FDA's publication of three draft guidances on direct-to-consumer advertising is unlikely to relieve pressure on the agency to explain its approach to enforcement actions against drug manufacturers that repeatedly run false and misleading promotions

More from Archive

More from Pink Sheet